TENOFOVIR VERSUS ENTECAVIR FOR HEPATOCELLULAR CARCINOMA PREVENTION IN AN INTERNATIONAL CONSORTIUM OF CHRONIC HEPATITIS B

被引：0

作者：

Hsu, Yao-Chun ^{[1
]}

Wong, Grace Lai-Hung ^{[2
,3
]}

Chen, Chien Hung ^{[4
]}

Peng, Cheng-Yuan ^{[5
]}

Yeh, Ming-Lun ^{[6
]}

Cheung, Ka-Shing ^{[7
]}

Toyoda, Hidenori ^{[8
]}

Huang, Chung-Feng ^{[9
]}

Trinh, Huy N. ^{[10
]}

Xie, Qing ^{[11
]}

Enomoto, Masaru ^{[12
]}

Liu, Li ^{[13
]}

Yasuda, Satoshi ^{[8
]}

Tanaka, Yasuhito ^{[14
,15
]}

Kozuka, Ritsuzo ^{[12
]}

Tsai, Pei-Chien ^{[6
]}

Huang, Yen-Tsung ^{[16
]}

Wong, Christopher ^{[17
]}

Huang, Rui ^{[18
]}

Jang, Tyng-Yuan ^{[19
]}

Hoang, Joseph ^{[20
]}

Yang, Hwai-I ^{[21
]}

Li, Jiayi ^{[22
]}

Lee, Dong Hyun ^{[23
]}

Takahashi, Hirokazu ^{[24
]}

Zhang, Jianqing ^{[25
]}

Ogawa, Eiichi ^{[26
]}

Zhao, Changqing ^{[27
]}

Liu, Chenghai ^{[28
]}

Furusyo, Norihiro ^{[26
]}

Eguchi, Yuichiro ^{[29
]}

Wong, Clifford ^{[17
]}

Wu, Chao ^{[18
]}

Kumada, Takashi ^{[30
]}

Yuen, Man-Fung ^{[31
]}

Yu, Ming-Lung ^{[6
]}

Nguyen, Mindie H. ^{[20
]}

机构：

[1] I Shou Univ, Kaohsiung, Taiwan

[2] Chinese Univ Hong Kong, Inst Digest Dis, Dept Med & Therapeut, Hong Kong, Peoples R China

[3] Chinese Univ Hong Kong, State Key Lab Digest Dis, Hong Kong, Peoples R China

[4] Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan

[5] China Med Univ, Sch Med, Taichung, Taiwan

[6] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Hepatobiliary Div, Dept Internal Med, Kaohsiung, Taiwan

[7] Queen Mary Hosp, Med, Hong Kong, Peoples R China

[8] Ogaki Municipal Hosp, Dept Gastroenterol, Ogaki, Gifu, Japan

[9] Kaohsiung Med Univ Hosp, Hepatobiliary Div, Dept Internal Med, Kaohsiung, Taiwan

[10] San Jose Gastroenterol, San Jose, CA USA

[11] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Infect Dis, Shanghai, Peoples R China

[12] Osaka City Univ, Grad Sch Med, Dept Hepatol, Osaka, Japan

[13] Third Hosp Kumming City, Kunming, Yunnan, Peoples R China

[14] Nagoya City Univ, Grad Sch Med Sci, Dept Virol, Nagoya, Aichi, Japan

[15] Nagoya City Univ, Grad Sch Med Sci, Liver Unit, Nagoya, Aichi, Japan

[16] Acad Sinica, Taipei, Taiwan

[17] Wong Clin, Singapore, Singapore

[18] Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Dept Infect Dis,Affiliated Hosp, Nanjing, Jiangsu, Peoples R China

[19] Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan

[20] Stanford Univ, Med Ctr, Div Gastroenterol & Hepatol, Stanford, CA 94305 USA

[21] Acad Sinica, Genom Res Ctr, Taipei, Taiwan

[22] Palo Alto Med Fdn, Mt View Div, Palo Alto, CA USA

[23] Good Gang An Hosp, Busan, South Korea

[24] Saga Univ, Fac Med, Div Endocrinol & Metab, Saga, Japan

[25] Chinese Hosp, Beijing, Peoples R China

[26] Kyushu Univ Hosp, Dept Gen Internal Med, Fukuoka, Fukuoka, Japan

[27] Shuguang Hosp, Inst Liver Dis, Shanghai, Peoples R China

[28] Shanghai Univ TCM, Shuguang Hosp, Inst Liver Dis, Shanghai, Peoples R China

[29] Saga Med Sch, Fac Med, Dept Internal Med, Saga, Japan

[30] Ogaki Municipal Hosp, Ogaki, Gifu, Japan

[31] Univ Hong Kong, Queen Mary Hosp, Hong Kong, Peoples R China

来源：

HEPATOLOGY | 2019年 / 70卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

459

引用

页码：290A / 291A

页数：2

共 50 条

[11] The Risk of Hepatocellular Carcinoma in Entecavir Versus Tenofovir Treated US Cohort With Chronic Hepatitis B Virus
Kramer, Jennifer R.
Richardson, Peter A.
Kim, Hyunseok
Hsu, Yao-Chun
Kanwal, Fasiha
El-Serag, Hashem B.
[J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (04) : 1111 - 1113
[12] Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir in Patients With Chronic Hepatitis B
Lee, Han Ah
Seo, Yeon Seok
Kim, Seung Up
[J]. GASTROENTEROLOGY, 2020, 158 (08) : 2310 - 2311
[13] No difference in hepatocellular carcinoma risk between chronic hepatitis B patients treated with entecavir versus tenofovir
Su, Feng
Berry, Kristin
Ioannou, George N.
[J]. GUT, 2021, 70 (02) : 370 - 378
[14] Letter: tenofovir versus entecavir for hepatocellular carcinoma prevention in chronic hepatitis B-related compensated cirrhosis-authors' reply
Chiu, Sherry Yueh-Hsia
Chang, Kuo-Chin
Hu, Tsung-Hui
Chien, Rong-Nan
[J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 53 (09) : 1042 - 1043
[15] Tenofovir vs Entecavir for Hepatocellular Carcinoma Prevention in Patients With Chronic Hepatitis B One of These Things Is Not Like the Other
Flemming, Jennifer A.
Terrault, Norah A.
[J]. JAMA ONCOLOGY, 2019, 5 (01) : 17 - 18
[16] Hepatocellular carcinoma incidence with tenofovir versus entecavir in chronic hepatitis B: a systematic review and meta-analysis
Tseng, Cheng-Hao
Hsu, Yao-Chun
Chen, Tzu-Haw
Ji, Fanpu
Chen, I-Sung
Tsai, Ying-Nan
Hai, Hoang
Le Thi Thanh Thuy
Hosaka, Tetsuya
Sezaki, Hitomi
Borghi, John A.
Cheung, Ramsey
Enomoto, Masaru
Nguyen, Mindie H.
[J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2020, 5 (12): : 1039 - 1052
[17] Efficacy of entecavir versus tenofovir in preventing hepatocellular carcinoma in patients with chronic hepatitis B with maintained virologic response
Na, Ji Eun
Sinn, Dong Hyun
Lee, Jeong-Hoon
Jang, Hee Joon
Baek, Seon Yeong
Kim, Kyung A.
Kang, Won Seok
Gwak, Geum-Youn
Paik, Young-Han
Kim, Yoon Jun
Choi, Moon Seok
Yoon, Jung-Hwan
Lee, Joon Hyeok
Koh, Kwang Cheol
Paik, Seung Woon
[J]. JOURNAL OF VIRAL HEPATITIS, 2021, 28 (10) : 1392 - 1399
[18] Comparable Incidence of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir
Jung Woo Shin
Joonho Jeong
Seok Won Jung
Seung Bum Lee
Bo Ryung Park
Min-Ju Kim
Eun Ji Park
Neung Hwa Park
[J]. Digestive Diseases and Sciences, 2021, 66 : 1739 - 1750
[19] OCCURRENCE OF HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B PATIENTS UNDERGOING ENTECAVIR OR TENOFOVIR TREATMENT
Lee, Chieh-Ju
Su, Chien-Wei
Lin, Han-Chieh
Hou, Ming-Chih
Huang, Yi-Hsiang
[J]. HEPATOLOGY, 2019, 70 : 578A - 579A
[20] Comparable Incidence of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir
Shin, Jung Woo
Jeong, Joonho
Jung, Seok Won
Lee, Seung Bum
Park, Bo Ryung
Kim, Min-Ju
Park, Eun Ji
Park, Neung Hwa
[J]. DIGESTIVE DISEASES AND SCIENCES, 2021, 66 (05) : 1739 - 1750

← 1 2 3 4 5 →